Media

SyVento Biotech has opened its new mRNA manufacturing facility, a FlexFactory delivered by Cytiva. This development represents a significant milestone for SyVento Biotech, enabling the CDMO to accelerate and enhance their service offerings to medicine manufacturers.

Cytiva opens its first Innovation Hub in Korea, located in the Songdo Bio-cluster in Incheon.

Cytiva and Pear Bio are setting new benchmarks in cancer research by utilizing advanced 3D tumor models and single-cell technology, revolutionizing personalized cancer treatment and improving patient outcomes.